Andere Sprachen ANGLE plc

Aktien

A0B7QK

GB0034330679

AGL

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:28 18.04.2024			% 5 Tage	% 1. Jan.
11,75 ^GBX	-4,08 %		-14,55 %	0,00 %

08.04.	ANGLE plc präsentiert den Parsortix HER2 Assay auf der AACR-Jahrestagung 2024	CI
06.02.	Transcript : ANGLE plc - Special Call

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ANGLE PLC - PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE	09.04.
ANGLE plc Presents Parsortix HER2 Assay at AACR Annual Meeting 2024	08.04.
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY	25.03.
ANGLE PLC - PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE	25.03.
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY	23.01.
Angle highlights supportive data for DNA analysis tool	22.01.
ANGLE PLC - BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCER	05.01.
Stocks up ahead of US nonfarm payrolls	04.01.
Angle shares soar following "breakthrough" cancer diagnostics results	04.01.
Retailers Next and JD Sports bookend FTSE 100	04.01.
AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up	04.01.
Next leads buoyant FTSE 100 amid services PMIs	04.01.
Angle Plc Outlines 'Breakthrough' Results from DNA Molecular Analysis of Cancer Patient Blood Samples; Stock Soars	04.01.
ANGLE plc Announces Clinical Results Provide A Unique Insight into the Progression of Each Patient's Cancer	04.01.
Angle PLC Shares Rise on Cancer Patient Blood Sample Analysis	04.01.
Angle teams with Japan's Eisai in breast cancer drug trial	02.01.
Angle plc Signs Contract with Eisai on Breast Cancer Study	02.01.
Angle plc Signs Contract with Eisai Inc	02.01.
Ondine Biomedical raises GBP2.9 million via placing	11.12.
Angle plc Announces Use of Parsortix System in Pre-Clinical Model Unlocks Opportunities for Drug Discovery	11.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ANGLE plc

Aktien

A0B7QK

GB0034330679

AGL

Andere Sprachen

Filter